Higher-end serotonin receptors: 5-HT5, 5-HT6, and 5-HT7

Journal of Medicinal Chemistry

Volumn 46, Issue 14, 2003, Pages 2795-2812

  Glennon, Richard A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 NAPHTHYLPIPERAZINE; 2 METHYLSEROTONIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 METHOXYTRYPTAMINE; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; DIPHENYLBUTYLPIPERIDINE DERIVATIVE; GAMMA CARBOLINE DERIVATIVE; HETEROCYCLIC COMPOUND; KETANSERIN; LOXAPINE; METITEPINE; MIANSERIN; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; QUIPAZINE; SEROTONIN; SEROTONIN 5 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SPIPERONE; THIOXANTHENE DERIVATIVE; TRYPTOLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZACOPRIDE;

BINDING AFFINITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; LIGAND BINDING; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

ANIMALS; HUMANS; LIGANDS; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0038460888     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030030n     Document Type: Review

References (101)

1. Glennon, R. A.; Dukat, M. Serotonin receptors and drugs affecting serotonergic neurotransmission. In Foye's Principles of Medicinal Chemistry; Williams, D. A., Lemke, T. M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, 2002; pp 315-337.
2. Hoyer, D.; Hannon, J. P.; Martin, G. R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 2002, 71, 533-554.
3. Kroeze, W. K.; Kristiansen, K.; Roth, B. L. Molecular biology of serotonin receptors - Structure and function at the molecular level. Curr. Top. Med. Chem. 2002, 2, 507-528.
4. Humphrey, P. P. A.; Hartig, P. R.; Hoyer, D. A new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 1993, 14, 233-236.
5. Barnes, N. M.; Sharp, T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38, 1083-1152.
6. 1D family. EMBO J. 1992, 11, 4779-4786.
7. 5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. Mol. Pharmacol. 1993, 43, 313-319.
8. Erlander, M. G.; Lovenberg, T. W.; Baron, B. M.; deLeccea, L.; Danielson, P. E.; Racke, M.; Slone, A. L.; Siegel, B. W.; Foye, P. E.; Cannon, K.; Burns, J. E.; Sutcliffe, J. G. Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 3452-3456.
9. 5B receptor. FEBS Lett. 1993, 333, 25-31.
10. 5A serotonin receptor. FEBS Lett. 1994, 355, 242-246.
11. 5B receptor was lost during mammalian evolution. Eur. J. Pharmacol. 2001, 418, 157-167.
12. Waeber, C.; Grailhe, R.; Yu, X. J.; Hen, R.; Moskowitz, M. A. Putative 5-ht5 receptors: localization in the mouse CNS and lack of effect in the inhibition of dural protein extravasation. Ann. N. Y. Acad. Sci. 1998, 861, 85-90.
13. Carson, M. J.; Thomas, E. J.; Danielson, P. A.; Sutcliffe, J. G. Glia 1996, 17, 317-326.
14. 5A receptors in the carotid body chemoreception pathway of rat. Neurosci. Lett. 2000 278, 9-12.
15. 5A receptor. Neuron 1999, 22, 581-591.
16. 5A gene in depression, psychosis and antipsychotic response. NeuroReport 2000, 11, 2017-2020.
17. 5A receptor gene in patients with bipolar disorder and major depression. Neurosci. Lett. 2001, 303, 111-114.
18. The Psychoactive Drug Screening Program Database can be found at http://pdsp.cwru.edu/pdsp.asp.
19. 5A serotonin receptor binding: A preliminary structure-affinity investigation. Med. Chem. Res. 1997, 7, 207-218.
20. 5A serotonin receptors. Bioorg. Med. Chem. Lett., in press.
21. 5A receptors. Presented at the 80th Annual Virginia Academy of Sciences Meeting, Hampton, VA, May 22-24, 2002 (abstract in the following: Va. J. Sci. 2002, 53, 98.).
22. Monsma, F. J.; Shen, Y.; Ward, R. P.; Hamblin, M. W.; Sibley, D. R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 1993, 43, 320-327.
23. Unsworth, C. D.; Molinoff, P. B. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells. J. Pharmacol. Exp. Ther. 1994, 269, 246-255.
24. 6 serotonin receptor. J. Neurochem. 1996, 66, 47-56.
25. Roth, B. L.; Craigo, S. C.; Choudhary, M. S.; Uluer, A.; Monsma, F. J.; Shen, Y.; Meltzer, H. Y.; Sibley, D. R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 1994, 268, 1403-1410.
26. Sleight, A. J.; Boess, F. G.; Bös, M.; Levet-Trafit, B.; Riemer, C.; Bourson, A. Characterization of Ro 04-6790 and Ro 63-0563: Potent and selective antagonists at human and rat 5-HT6 receptors. Br. J. Pharmacol. 1998, 124, 556-562.
27. 6 receptor antagonist. J. Med. Chem. 1999, 42, 202-205.
28. 6 antagonists. Bioorg. Med. Chem. Lett. 2000, 10, 2295-2299.
29. 6 serotonin receptors. J. Med. Chem. 2000, 43, 1011-1018.
30. 6 receptor antagonists: Lead optimization and biological evaluation of N-aryl and N-heteroaryl 4-aminobenzene sulfonamides. Eur. J. Med. Chem. 2001, 36, 165-178.
31. 3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum. Mol. Pharmacol. 1998, 54, 577-583.
32. Bromidge, S. M.; Clarke, S. E.; Gager, T.; Griffith, K.; Jeffrey, P.; Jennings, A. J.; Joiner, G. F.; King, F. D.; Lovell, P. J.; Moss, S. F.; Newman, H.; Riley, G.; Rogers, D.; Routledge, C.; Serafinowska, H.; Smith, D. R. Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: Identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzene-sulfonamide (SB-357134). Bioorg. Med. Chem. Lett. 2001, 11, 55-58.
33. 5 receptor antagonists. Bioorg. Med. Chem. Lett. 2002, 12, 1357-1360.
34. Slassi, A.; Isaac, M.; O'Brien, A. Recent progress in 5-HT6 receptor antagonists for the treatment of CNS diseases. Expert Opin. Ther. Pat. 2002, 12, 513-527.
35. 125I]-SB-258585 binding to human recombinant and native 5-HT6 receptors in rat, pig and human brain tissue. Br. J. Pharmacol. 2000, 130, 1597-1605.
36. 6 serotonin receptor binding of indolealkylamines: A preliminary structure-affinity investigation. Med. Chem. Res. 1999, 9, 108-117.
37. 6 serotonin receptor binding affinities of N1-benzenesulfonyl and related tryptamines. Med. Chem. Res. 2000, 10, 230-242.
38. 6 receptor ligands. J. Med. Chem. 2001, 44, 3881-3895.
39. 6 Receptor Ligand Templates. Bioorg. Med. Chem. Lett., in press.
40. 6 serotonin receptors may reflect psychoactive profile. Mol. Med. 1995, 1, 398-406.
41. 6) receptor gene in bipolar affective disorder and schizophrenia. Am. J. Med. Genet. 2000, 96, 217-221.
42. 6 receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacol. Biochem. Behav. 2002, 71, 635-643.
43. 125I]SB-258585. Synapse 2002, 45, 191-199.
44. 6 receptor. Synapse 2003, 47, 218-224.
45. 6 receptor in the rat brain: A study using antisense oligonucleotides. J. Pharmacol. Exp. Ther. 1995, 274, 173-180.
46. 6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 2001, 41, 210-219.
47. 6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berlin) 2001, 158, 114-119.
48. 6 receptor ligands and their biological functions. Curr. Top. Med. Chem. 2002, 2, 643-654.
49. 6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 2001, 25, 662-668.
50. 6 receptor antagonist. Pharmacol. Biochem. Behav. 2002, 71, 645-654.
51. 6 receptor antagonist. Br. J. Pharmacol. 2000, 130, 1606-1612.
52. 7 receptor: Orphan found. Trends Pharmacol. Sci. 1997, 18, 104-107.
53. 7 receptors: Current knowledge and future prospects. Trends Pharmacol. Sci. 2000, 21, 70-77.
54. 7 serotonin receptor subtype. J. Biol. Chem. 1993, 268, 18200-18204.
55. 7) implicated in the regulation of mammalian circadian rhythms. Neuron 1993, 11, 449-458.
56. 7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 8547-8551.
57. Plassat, J.-L.; Amlaiky, N.; Hen, R. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol. 1993, 44, 229-236.
58. 7 receptor positively coupled to adenylyl cyclase. J. Neurochem. 1994, 63, 456-464.
59. 7 receptor and its comparison with the structure of other species. Mol. Cell. Biochem. 2002, 238, 81-88.
60. 7) positively linked to adenylate cyclase. J. Biol. Chem. 1993, 268, 23422-23426.
61. 7b). Br. J. Pharmacol. 1997, 122, 126-132.
62. 7 receptor: Cloning and pharmacological characterization of two receptor variants. FEBS Lett. 1997, 413, 489-494.
63. 7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J. Neurochem. 1997, 68, 1372-1381.
64. 7) receptor isoforms produced by alternative splicing. Neuropharmacology 1998, 37, 1621-1632.
65. 7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn-Schmiedeberg's Arch. Pharmacol. 2001, 363, 620-632.
66. 7 receptor (long form); antagonist profile of SB-258719. Br. J. Pharmacol. 1998, 124, 1300-1306.
67. Krobert, K. A.; Levy, F. O. The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects. Br. J. Pharmacol. 2002, 135, 1563-1571.
68. 2A antagonists. Curr. Top. Med. Chem. 2002, 2, 539-558.
69. 7 receptor antagonist. J. Med. Chem. 1998, 41, 655-657.
70. 7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). J. Med. Chem. 2000, 43, 342-345.
71. 7 receptor antagonist with improved in vivo properties. Bioorg. Med. Chem. Lett. 2002, 12, 3341-3344.
72. 7 receptor. J. Med. Chem. 1999, 42, 533-535.
73. 7 receptor, J. Med. Chem. 2002, 45, 2197-2206.
74. 7 receptor antagonists. J. Med. Chem. 2001, 44, 1337-1340.
75. Linnanen, T.; Brisander, M.; Unelius, L.; Sundholm, G.; Hacksell, U.; Johansson, A. M. Derivatives of (R)-1,11-methyleneaporphine: synthesis, structure, and interactions with G-protein coupled receptors. J. Med. Chem. 2000, 43, 1339-1349.
76. 7 receptor ligands. Bioorg. Med. Chem. Lett. 2002, 12, 2451-2454.
77. 7 agonists. Bioorg. Med. Chem. Lett. 2003, 13, 269-271.
78. 7 receptors. J. Comput.-Aided Mol. Des. 2001, 15, 883-909.
79. Lawler, C. P.; Prioleau, C.; Lewis, M. M.; Mak, C.; Jiang, D.; Schertz, J. A.; Gonzalez, A. M.; Sibley, D. R.; Mailman, R. B. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 1999, 20, 612-627.
80. 7 receptors in HeLa cells. Neurosci. Lett. 2000, 288, 236-240.
81. 7 receptor antagonist SB-258741 in animal models for schizophrenia. Pharmacol. Biochem. Behav. 2002, 71, 655-665.
82. Jovanovska, A.; Prosser, R. A. Translational and transcriptional inhibitors block serotonergic phase advances of the suprachiasmatic nucleus circadian pacemaker in vitro. J. Biol. Rhythms 2002, 17, 137-146.
83. Biello, S. M.; Dafters, R. I. MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro. Brain Res. 2001, 920, 202-209.
84. 7 neurons in mouse thalamus and hypothalamus. J. Neurochem. 1999, 72, 2370-2378.
85. 7 receptors. Biochem. Pharmacol. 1999, 58, 1807-1813.
86. 7 receptor. Dev. Brain Res. 2002, 139, 199-203.
87. De Ponti, F. Tonini, M. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs 2001, 61, 317-332.
88. 7 receptors mediating relaxation of human colonic circular smooth muscle. Br. J. Pharmacol. 1999, 128, 849-852.
89. 7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat. Br. J. Pharmacol. 1997, 121, 563-571.
90. 7 receptor mediating smooth muscle relaxation in canine cerebral arteries. Br. J. Pharmacol. 1999, 127, 609-616.
91. Villalon, C. M.; Centurion, D.; Valdivia, L. F.; De Vries, P.; Saxena, P. R. An introduction to migraine: From ancient treatment to functional pharmacology and antimigraine therapy. Proc. West. Pharmacol. Soc. 2002, 45, 199-210.
92. 7 receptor involved in the pathogenesis and prophylactic treatment of migraine? Eur. J. Pharmacol. 2002, 439, 1-11.
93. 7 receptors are involved in mediating 5-HT-induced activation of rat primary afferent neurons. Life Sci. 2002, 71, 2279-2289.
94. 7 receptor. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 361, 665-671.
95. 7 receptor affinity and protection against sound-induced seizures in DBA/2J mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 356, 820-826.
96. 7 receptors in the facilatory response induced by 8-OH-DPAT on learning consolidation. Behav. Brain Res. 2001, 121, 21-28.
97. Pouzet, B. SB-258741: A 5-HT7 receptor antagonist of potential clinical interest. CNS Drug Rev. 2002, 8, 90-100.
98. Langlois, M.; Fischmeister, R. 5-HT4 receptor ligands: Applications and new prospects. J. Med. Chem. 2003, 46, 321-344.
99. 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways. J. Neurochem. 2003, 84, 222-232.
100. 6 receptor agonists. Drugs Fut. 2002, 27 (Suppl. A), 369.
101. 7 antagonism. Bioorg. Med. Chem. Lett. 2000, 10, 1097-1100.